BDBM42272 2-[4-(5-phenyl-1,3,4-oxadiazol-2-yl)phenoxy]acetic acid ethyl ester::MLS000031798::SMR000002388::[4-(5-Phenyl-[1,3,4]oxadiazol-2-yl)-phenoxy]-acetic acid ethyl ester::cid_647355::ethyl 2-[4-(5-phenyl-1,3,4-oxadiazol-2-yl)phenoxy]acetate::ethyl 2-[4-(5-phenyl-1,3,4-oxadiazol-2-yl)phenoxy]ethanoate

SMILES OC[C@@H](CC(C)C)NC1=NC(=NC(=N1)C[C@H](C)C1=CC=CC=C1)NS(=O)(=O)C

InChI Key InChIKey=BZAQOWWLZDSWSH-UHFFFAOYSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 42272   

TargetCX3C chemokine receptor 1(Human)
Astrazeneca

WIPO
LigandChemical structure of BindingDB Monomer ID 42272BDBM42272(N-(4-(((R)-1-Hydroxy-4-methylpentan-2-yl)amino)-6-...)
Affinity DataIC50: 1.00E+4nMAssay Description:The mutation underlying Huntington's disease is an expansion of a polyglutamine tract in the N-terminus of the protein huntingtin (htt). Under no...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/23/2026
Entry Details
US Patent